Novacyt says the Franco-British biotech company can offer a coronavirus test that is faster than rival methods by focusing on a narrow sequence of DNA coding.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2020-02-11 06:53:412020-02-12 14:19:37Novacyt biotech company says winning race for high-speed virus test
